CSI Market
Sign In | Register

Rockwell Medical inc (RMTI) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access RMTI quarterly Cash Flow →
Cash flow patterns shown here provide context for understanding Rockwell Medical inc's ability to sustain operations and capital deployment.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-5.31
Depreciation & amortization2.19
Amortization of Other Assets0.35
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.25
Increase (Decrease) in Inventories2.53
Research and Development in Process0.00
Gain (Loss) on Disposition of Assets, Total0.06
Share-based Compensation1.82
Income (Loss) from Equity Method Investments0.00
Gain (Loss) on Contract Termination-0.02
Issuance Of Stock And Warrants And Other Equity Based Compensation For Services Or Claims-
Deferred Revenue Period Increase Decrease-
Restricted Stock Tendered In Satisifaction Of Tax Liabilities-
Restricted Stock Tendered In Satisfaction Of Tax Liabilities-
Restricted Stock Retained In Satisfaction Of Tax Liabilities-
Available For Sale Securities Gross Realized Losses-
Operating Lease Right Of Use Asset Amortization-
Debt Securities Available For Sale Realized Gain Loss-0.27
Operating Lease Right Of Use Asset Amortization Expense-
Increase Decreasein Operating Lease Liabilities-
Operating And Finance Lease Right Of Use Asset Amortization Expense2.14
Increase Decrease In Contract With Customer Liability-1.66
Income taxes0.00
Gain (Loss) on Sale of Investments0.00
Increase (Decrease) in Accounts Receivable-0.10
Increase (Decrease) in Accounts Payable-0.87
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.39
Other Working Capital-1.61
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-0.54
Discontinued operations0.00
Net Cash flow from Operating Activities-0.66
Investing Activities
Capital Expenditures-0.54
Sale of Capital Items0.00
Proceeds from Sale of Available-for-sale Securities, Debt16.20
Payments to Acquire Available-for-sale Securities, Debt-24.20
Real Estate Investments0.00
Payments To Acquire Machinery And Equipment Excluding Cash Paid In Asset Acquisition-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire in Process Research and Development0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-8.54
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-0.66
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock7.82
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-15.66
Proceeds From Issuance Of Common Shares And Purchase Warrants-
Payments For Surrender Of Stock For Satisfaction Of Tax Liabilities-
Repurchase Of Common Shares To Pay Employee Withholding Taxes-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents15.66
Research and Development Licenses Related Party-
Research And Development Licenses Included In Settlement Payable-
Payments Of Stock Issuance Costs Preferred Stock-
Finance Lease Principal Payments-0.53
Payment For Asset Acquisition Deferred Consideration-2.37
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities4.25
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-1.20
Total Cash Flow-4.95
4 historic quarters locked

Sign in to unlock the full Rockwell Medical inc cash flow history.

Sign In Create Free Account

About Rockwell Medical Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001628280-26-021186

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License